Royal Bank Of Canada Pfizer Inc Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Pfizer Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 33,740,054 shares of PFE stock, worth $782 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

33,740,054

Previous 33,491,049 0.74%

Holding current value

$782 Million

Previous $889 Million 3.78%

% of portfolio

0.19%

Previous 0.19%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $6.23 Million - $6.76 Million	249,005 Added 0.74%	33,740,054 $855 Million
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $38.2 Million - $46.5 Million	1,541,076 Added 4.82%	33,491,049 $889 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $155 Million - $176 Million	5,606,285 Added 21.28%	31,949,973 $925 Million
Q2 2024 Nov 06, 2024	SELL	$25.26 - $29.6 $5.2 Million - $6.1 Million	-206,002 Reduced 0.78%	26,343,688 $737 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $214 Million - $250 Million	8,452,999 Added 46.71%	26,549,690 $743 Million
Q1 2024 Nov 05, 2024	SELL	$25.89 - $29.73 $224 Million - $258 Million	-8,664,122 Reduced 32.63%	17,885,568 $496 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $74.4 Million - $85.5 Million	-2,874,906 Reduced 13.71%	18,096,691 $502 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $10.9 Million - $14.2 Million	-418,026 Reduced 1.95%	20,971,597 $604 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $108 Million - $126 Million	-3,353,225 Reduced 13.55%	21,389,623 $709 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $124 Million - $144 Million	3,441,924 Added 16.16%	24,742,848 $908 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $164 Million - $214 Million	-4,164,772 Reduced 16.35%	21,300,924 $869 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $92.1 Million - $120 Million	2,205,588 Added 9.48%	25,465,696 $1.31 Billion
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $91.9 Million - $112 Million	-2,101,194 Reduced 8.29%	23,260,108 $1.02 Billion
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $74.2 Million - $87.9 Million	-1,593,788 Reduced 5.91%	25,361,302 $1.33 Billion
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $28.3 Million - $35 Million	-618,016 Reduced 2.24%	26,955,090 $1.4 Billion
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $54.3 Million - $80.5 Million	1,314,618 Added 5.01%	27,573,106 $1.63 Billion
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $35.3 Million - $45.4 Million	899,716 Added 3.55%	26,258,488 $1.13 Billion
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $911 Million - $1.03 Billion	25,358,772 New	25,358,772 $993 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $130B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Pfizer Inc Transaction History